SCHEMBL22609297

SCHEMBL22609297

O=C(O)c1nnccc1NCc1ccc(F)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P4HTM Q9NXG6 1/20 0.48
▸ KMT2A Q03164 2/20 0.47
▸ KDM5B Q9UGL1 2/20 0.46
▸ RPS6KB1 P23443 1/20 0.43
▸ PPARA Q07869 2/20 0.43
▸ CISD1 Q9NZ45 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ STING1 Q86WV6 1/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ F2 P00734 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ KDM4C Q9H3R0 2/20 0.40
▸ ASPH Q12797 1/20 0.40
▸ KDM8 Q8N371 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ KDM6B O15054 1/20 0.40
▸ KDM4A O75164 1/20 0.40
▸ KDM4D Q6B0I6 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23486276 0.85 MAPT (0.46) P4HTMKMT2AKDM5BRPS6KB1L3MBTL1
SCHEMBL22609254 0.78 DHODH (0.46) P4HTMKMT2AHTTALDH1A1RAB9A
SCHEMBL6103736 0.77 KDM5B (0.76) P4HTMKMT2AKDM5BRPS6KB1PPARA
SCHEMBL22609307 0.75 KMT2A (0.41) P4HTMKMT2AL3MBTL1
SCHEMBL15528783 0.74 KMT2A (0.56) P4HTMKMT2ARPS6KB1PPARAL3MBTL1
SCHEMBL19422692 0.73 P4HTM (0.53) P4HTMKMT2AKDM5BRPS6KB1PPARA
SCHEMBL29582097 0.71 KDM4C (0.76) KDM5BKDM4CKDM4EKDM6BKDM4A
SCHEMBL15818320 0.71 KDM4C (0.76) KDM5BKDM4CKDM4EKDM6BKDM4A
SCHEMBL1715225 0.70 ALDH1A1 (0.74) KMT2AKDM5BPPARACISD1L3MBTL1
SCHEMBL7012861 0.69 RPS6KB1 (0.55) P4HTMKDM5BRPS6KB1L3MBTL1KDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF ORFAN BIOTECH SL (ES) 2021-06-10 — — US disclosed
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF ORFAN BIOTECH SL (ES) 2021-06-10 — — US disclosed
EP-3731840-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF Orfan Biotech Inc. (US) 2020-11-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF PNPO, XDH, GLS P4HTM 1453/4885KMT2A 3407/4885KDM5B 1381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback